What is STAR® technology

STAR® technology is a gene expression technology. Acquired by Crucell in 2004, it has proved extremely valuable for increasing production of recombinant antibodies and therapeutic proteins on mammalian cell lines.

Key strengths

• STAR® technology uses well-established mammalian cell banks for protein and antibody production, thereby eliminating the need for specially engineered mammalian cells

• STAR® technology allows for very rapid, stable mammalian cell clone generation

• STAR® technology typically generates stable mammalian cell clones that produce 5 to 10 times more antibody or other therapeutic protein than cell clones generated without STAR® technology